Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern? - Wikidata - wikimedia - TriplyDB

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

http://www.wikidata.org/entity/Q58701953

about

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

http://www.wikidata.org/entity/Q58701953

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

@en

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

@nl

type

label

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

@en

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

@nl

prefLabel

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

@en

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

@nl

P1433

Q58701953-C0FC8B84-B93B-4F4A-9787-0570EFBF4102

P1476

Q58701953-6BE5FCDD-313C-4913-9CCA-BFB4FD89CEB6

P2093

Q58701953-B47DCB52-104E-4726-894A-A9876324A020

Q58701953-B7F314FC-1BB1-446E-8F25-FE6CA20F9EEE

P2860

Q58701953-04D26993-1644-4882-BEE3-4456023F57F3

Q58701953-0CD213A1-E11D-4DA6-B261-8E47A36CDF61

Q58701953-0F151EBD-6942-4ED2-9440-CF5FC9C65F1C

Q58701953-12B11F16-8356-4286-B3BB-DD42FC10C0DD

Q58701953-17426DCF-FEA4-4B8F-A9D7-0F24FE22EC0B

Q58701953-17FA8FFD-A87C-4EB3-A517-781D9673E321

Q58701953-1B510EC6-E3E0-405A-9949-94419E365F0C

Q58701953-1E03B04B-F8AA-4548-939F-787FF0C70320

Q58701953-21550743-47C3-4B3E-B811-E08F0F9F3A3D

Q58701953-23C4698B-7A25-498B-861B-34AFB9893DE1

P304

Q58701953-168CABC8-4D13-44B9-9209-AA0ED5157F8D

P31

Q58701953-2FD5AF29-570C-4BCA-BDD1-A1F674F76D87

P356

Q58701953-2608D7A8-B710-4CF6-AE34-5FA371CEA89B

P407

Q58701953-20DEA002-31ED-4021-AAA6-F1A15C429ADE

P478

Q58701953-4C48090B-EAF1-4D0C-8EA4-7FC1151FE42B

P50

Q58701953-A2CD30A6-70C9-4DE5-A831-9A2884AD9F51

Q58701953-B10F6DCC-E7AD-4D9A-86FD-4E859F616C4E

P577

Q58701953-312A3524-7DCA-4104-A09D-C55C25A18BEF

P698

Q58701953-CCB1B619-4E24-4AB1-AB48-85684C5EB7AF

P932

Q58701953-6CEE6DC4-5596-4DBD-B493-336840C87354

P356

1178221818801311

P1433

Substance Abuse: Research and Treatment

P1476

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

@en

P2093

Kirk E Evoy

http://www.w3.org/2001/XMLSchema#string

Leslie Ochs

http://www.w3.org/2001/XMLSchema#string

P2860

Anticonvulsants for cocaine dependence

Anticonvulsants for alcohol dependence

Gabapentin add-on for drug-resistant partial epilepsy

Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults

Single dose oral gabapentin for established acute postoperative pain in adults

Therapeutic-class wars--drug promotion in a competitive marketplace

Abuse and Misuse of Pregabalin and Gabapentin.

Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.

Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety.

False Claims Act prosecution did not deter off-label drug use in the case of neurontin.

P304

1178221818801311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1178221818801311

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Alyssa M Peckham

Jordan R Covvey

P577

2018-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30262984

http://www.w3.org/2001/XMLSchema#string

P932

6153543

http://www.w3.org/2001/XMLSchema#string